Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 22, 2024Cancer Research

Abstract 1223: KDM6A orchestrates NK cell response via CD38/48 regulation in multiple myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

JLJiye LiuShandong First Medical UniversityLXLijie XingShandong Tumor HospitalJLJiang LiJiangsu University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liu et al. (2024) studied this question.

synapsesocial.com/papers/68e72ce8b6db6435876a6fc8https://doi.org/10.1158/1538-7445.am2024-1223
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma2024 · 39 citations
  2. 2Abstract 1890: HMA800067, a novel CD38-targeting antibody-drug conjugate (ADC), demonstrated superior anti-tumor activity to daratumumab in preclinical B-cell malignancies models2024
  3. 3Leveraging novel CD38 targeted antibody-drug-conjugates for the treatment of multiple myeloma2025 · 1 citations
  4. 4Abstract 1718: The lysine demethylase KDM2A regulates tumor cell clustering to potentiate metastasis2024
  5. 5Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspective2026 · 4 citations